Cellectar BiosciencesCLRB
13F holders, Q3 2024 (September 30)35holders −2
5new positions
7sold out
1famous investor
$2.14avg. 13F price*
At the end of Q3 2024, 35 institutions reported holding Cellectar Biosciences Inc. (CLRB) in their 13F filings, down 2 from Q2 2024. 5 opened new positions and 7 sold out. The largest holders were Rosalind Advisors, Inc. ($7.9M), AIGH Capital Management LLC ($6.8M) and Nantahala Capital Management, LLC ($5.8M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Cellectar Biosciences Inc.
- CUSIP
- 15117F807
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $640K |
| Exits | 7 | $831K |
All 13F filers, Q2 2024 → Q3 2024: 2,977,515 shares bought and 569,259 shares sold, net +2,408,256 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 35 holders
| Rosalind Advisors, Inc. | 5.21% | Add +35.7% | 3,671,550 | $7.9M |
| AIGH Capital Management LLC | 3.20% | Add +5.3% | 3,197,394 | $6.8M |
| Nantahala Capital Management, LLC | 0.49% | Add +48.0% | 2,712,443 | $5.8M |
| Vanguard Group Inc. | 0.00% | Add +10.4% | 1,726,986 | $3.7M |
| ADAR1 Capital Management, LLC | 0.37% | Add +49.9% | 1,022,161 | $2.2M |
| Geode Capital Management, LLC | 0.00% | Add +3.3% | 352,452 | $754K |
| BlackRock, Inc. | 0.00% | — | 232,320 | $497K |
| Altium Capital Management LLC | 0.14% | New | 215,000 | $460K |
| Bank of America Corp. | 0.00% | Add +161.7% | 165,079 | $353K |
| Morgan Stanley | 0.00% | Add +66.9% | 139,231 | $298K |
| Barclays PLC | 0.00% | Reduce -30.0% | 120,497 | $258K |
| State Street Corp. | 0.00% | No change | 116,814 | $250K |
| Northern Trust Corp. | 0.00% | No change | 61,094 | $131K |
| XTX Topco Ltd | 0.01% | Reduce -16.2% | 53,022 | $113K |
| Raymond James Financial Services Advisors, Inc. | 0.00% | No change | 30,000 | $64K |
| Pale Fire Capital SE | 0.01% | New | 25,030 | $54K |
| Sequoia Financial Advisors, LLC | 0.00% | New | 23,800 | $51K |
| JPMorgan Chase & Co. | 0.00% | Reduce -54.7% | 23,169 | $50K |
| Two Sigma Securities, LLC | 0.00% | New | 22,799 | $49K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -41.4% | 20,525 | $44K |
| Integrated Wealth Concepts LLC | 0.00% | No change | 20,000 | $43K |
| Susquehanna International Group, LLP | 0.00% | Reduce -64.7% | 16,134 | $35K |
| Commerce Bank | 0.00% | No change | 14,000 | $30K |
| Oppenheimer & Co. Inc. | 0.00% | New | 12,500 | $27K |
| Osaic Holdings, Inc. | 0.00% | No change | 2,846 | $6K |
| UBS Group AG | 0.00% | Reduce -82.6% | 2,577 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -92.8% | 2,285 | $5K |
| Group One Trading LLC | 0.00% | Reduce -71.8% | 1,398 | $3K |
| Bfsg, LLC | 0.00% | No change | 1,000 | $2K |
| US Bancorp \de | 0.00% | No change | 385 | $824 |
| Citadel Advisors | 0.00% | Reduce -99.4% | 303 | $648 |
| EnRich Financial Partners LLC | 0.00% | No change | 102 | $218 |
| Harbour Investments, Inc. | 0.00% | No change | 40 | $86 |
| AllSquare Wealth Management LLC | 0.00% | No change | 18 | $39 |
| Simplex Trading, LLC | 0.00% | Reduce -94.8% | 425 | $0 |
"% of holder's portfolio" is CLRB's weight in each manager's 13F, not the share of Cellectar Biosciences Inc. the manager owns.